baber/WOPTO huggingface dataset:
Patent CA-2560502-A1 (CA)
Inventor: VESELIC DUSAN
IPC: G06F1/26
Filed: 2003-02-21
Abstract: A convenient source of charging power for portable communication devices is an integral power node of a computer data bus, such as a USB (universal serial bus) port. Unfortunately, USB ports have limited power capacity, making them generally incompatible with battery charge controllers (BCCs) which are designed to receive a steady, high capacity input. The invention provides a battery charging circuit which adjusts to the parameters of an external power supply such as a USB port by adding a regulating circuit to a standard BCC design. This regulating circuit maximizes the current drawn by the BCC, while keeping the voltage to the BCC above a preset minimum (the low voltage shut off level for the BCC). if the voltage to the BCC begins to drop, the regulating circuit reduces the current drawn, so the voltage rises and stays within the operating range of the BCC.
Patent CA-2562527-A1 (CA)
Title: Polymer conjugate releasable under mild thiolytic conditions
Inventor: SUBRAMONY PARAMJEET
IPC: A61K49/00
Filed: 2005-04-20
Abstract: Conjugates of formula (I) comprising a lipid or a hydrophilic polymer, such as polyethyleneglycol, linked to a ligand derived from an amine- or hydroxyl-containing compound, such as a drug or protein, are stable under conditions of storage, and are cleavable under mild thiolytic conditions to regenerate the amine- or hydroxyl-containing compound in its native form, without the formation of undesirable side products.
Patent CA-2563635-A1 (CA)
Title: Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine a2a receptor antagonists
Inventor: STAMFORD ANDREW
IPC: A61K31/519
Filed: 2005-04-19
Abstract: Compounds having the structural formula I or a pharmaceutically acceptable salt thereof, wherein R is optionally substituted phenyl, furanyl, thienyl, pyridyl, pyridyl N-oxide, oxazolyl or pyrrolyl, or cycloalkenyl R1, R2, R3, R4 and R5 are H, alkyl or alkoxyalkyl; and Z is optionally substituted aryl or heteroaryl are disclosed. Also disclosed is the use of compounds of formula I  in the treatment of central nervous system diseases, in particular Parkinson's disease, alone or in combination with other agents for treating Parkinson's disease, and pharmaceutical compositions comprising them.
Patent CA-2564062-A1 (CA)
Title: Indole derivative having piperidine ring
Inventor: SASAKI ATSUSHI
IPC: C07D413/14
Filed: 2005-05-11
Abstract: Compounds represented by the general formula (I) or pharmacologically acceptable salts thereof; and use of the same as drugs: [wherein R1 and R2 are adjacent substituents and R1 and R2 together with the two carbon atoms to which they are bonded respectively form a 5- to 7-membered nonaromatic hydrocarbon ring which may have one to four substituents selected from among (1) oxo, (2) hydroxyl, an so on; R3 is hydrogen or the like; and R6 is hydrogen or the like]. The compounds exhibit the ability to combine with 5-HT1A receptor and 5-HT1A receptor antagonism and are useful as therapeutic or preventive agents for lower urinary tract symptoms, particularly urine accumulation symptom.
Patent CA-2564285-A1 (CA)
Inventor: KIRKUP MICHAEL G
IPC: G06F9/44
Filed: 2005-04-29
Abstract: Systems and methods of owner application control of an electronic device are provided. Owner application control information is stored on the electronic device and/or one or more remote servers. Owner application control information is consulted to determine if one or more required applications are available for execution on the electronic device. If not, one or more required applications not available are downloaded and installed. This could be in a manner transparent to the user of the electronic device. If one or more required applications are not available on the electronic device, the device can be functionally disabled in whole, or in part, until one or more required applications are available.
Patent CA-2564783-A1 (CA)
Inventor: NAICKER THEO
IPC: G07F17/32
Filed: 2006-10-20
Abstract: A central gaming server communicates with a gaming workstation over a network, such as a local area network or wide area computer network. The gaming server makes an initial determination of payout percentage for an instance of a game engaged in by the workstation, and generates results of turns of the game in accordance with the initial payout percentage. In one embodiment, the payout percentage is dynamically changed by the gaming server, and it generates additional results of turns of the game using the new payout percentage. Triggers for determining a new payout percentage could be that a predetermined number of turns of play at the initial payout percentage have occurred, the elapsing of a certain amount of time, or the player logging off the game and then logging back on. In further embodiments, the gaming workstation includes a processor and instructions for locally determining an initial payout percentage, the results of play, and dynamically changing the payout percentage without requiring communication with a central gaming server.
Patent CA-2565492-A1 (CA)
Title: Devices for delivering therapeutic or diagnostic agents
Inventor: RIOUX ROBERT F
IPC: A61M25/00
Filed: 2005-05-06
Abstract: An agent delivery device (10) includes an inner tubular body (20) having a proximal end (24), a sharpened distal end (22), a delivery lumen (26) extending therebetween, and one or more outlet ports (27) on the distal end communicating with the delivery lumen. The device also includes one or more seals (29) sealing the one or more outlet ports, the one or more seals capable of being melted to allow a fluid to be delivered from the delivery lumen through the one or more outlet ports. The agent delivery device may further include a monopolar or bipolar electrode (50) and/or a radio-opaque marker carried at the distal end of the device. The inner tubular body can be made from a conductive material to thereby allow the inner tubular body to function as an electrode.
Patent CA-2566535-A1 (CA)
Title: Ige-retargeting, function-altering molecules (erfam) for treatment of allergic diseases
Inventor: LACK GIDEON DR
IPC: C07K16/18
Filed: 2005-05-19
Abstract: The invention provides an IgE-Retargeting, Function-Altering Molecules (ERFAM) construct of the formula A'-B', wherein A' represents a moiety that binds an IgE and B' represents a moiety that binds an inhibitory receptor; or a construct of the formula A'-X-B', wherein A' represents a moiety that binds an IgE, X represents a linker moiety, B' represents a moiety that binds an inhibitory receptor. Also provided are their methods of use in treating IgE-related disorders, e.g., allergy.
Patent CA-2566910-A1 (CA)
Title: Cap, particularly a disinfection cap, detection device for peritoneal dialysis, bag set for peritoneal dialysis, and use thereof
Inventor: BIESEL WOLFGANG
IPC: A61J1/00
Filed: 2005-06-03
Abstract: The invention relates to a cap, particularly a disinfection cap, for protecting and/or closing the abdominal connection for peritoneal dialysis, and to a detection device for peritoneal dialysis. The invention also relates to a bag set for peritoneal dialysis and to the use thereof. In consideration of the, in part, serious consequences of an incorrect liquid sequence in the abdominal cavity, the invention aims to prevent an incorrect liquid sequence during peritoneal dialysis. To this end, the invention provides that the cap, particularly the disinfection cap, has information concerning the medium respectively located in the abdominal cavity of the patient. This makes it possible, at any time, even after the abdominal cavity has been filled and the bag has been disposed of, of ascertaining the medium presently located inside the abdominal cavity and or of detecting other information such as amount, concentration, manufacturer, etc. of the medium, and to take these into consideration, in particular, during subsequent steps of the peritoneal dialysis.
Patent CA-2567183-A1 (CA)
Title: Method and apparatus for calculating an initial transmission power in universal mobile telecommunications system user equipment
Inventor: NORTON MARK DENNIS
IPC: H04B7/005
Filed: 2006-11-03
Abstract: A method and apparatus for calculating an initial transmission power in a mobile telecommunications system is disclosed, the system comprising a network of a plurality of cells and at least one user equipment device. The user equipment device receives broadcast system information, and measures a signal power. An initial transmission power is calculated in a lowest logical layer of the system defined as a protocol stack, using the received information and measured power.
Patent CA-2568354-A1 (CA)
Title: Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
Inventor: CHANG ESTHER H
IPC: C12N15/88
Filed: 2006-12-04
Abstract: The present invention provides methods of preparing an antibody- or antibody fragment-targeted cationic immunoliposome or polymer complex comprising (a) preparing an antibody or antibody fragment; (b) mixing said antibody or antibody fragment with a cationic liposome to form a cationic immunoliposome or with a cationic polymer to form a polyplex; and (c) mixing said cationic immunoliposome or said polyplex with a therapeutic or diagnostic agent to form said antibody- or antibody fragment-targeted cationic immunoliposome or polymer complex. The present invention also provides cationic immunoliposome or polymer complexes produced by such methods and compositions comprising such complexes. The present invention also provides methods for treating various diseases and disorders, including cancers, by administering the complexes and compositions of the invention to a patient.
Patent CA-2569139-A1 (CA)
Title: Lapatinib with letrozole for use in a treatment of breast cancer
Inventor: GILMER TONA MORGAN
IPC: A61K31/47
Filed: 2005-06-03
Abstract: The present invention relates to a method of treating cancer in a mammal by administration of 4-quinazolinamines and at least one additional anti-neoplastic compound. In particular, the method relates to a methods of treating cancers by administration of N-{3-chloro-4-[(3-fluorobenzyl) oxy]phenyl}-6-[5-({[2-(methanesulphonyl) ethyl]amino} methyl)-2-furyl]-4-quinazolinamine and salts and solvates thereof in combination with at least one additional anti-neoplastic compound.
Patent CA-2570881-A1 (CA)
Title: Method, system and apparatus for conveying personalized content to a viewer
Inventor: POPA OVIDIU OCTAVIAN
IPC: H04N7/16
Filed: 2006-09-01
Abstract: A method, system and apparatus for conveying personalized content to a viewer associated with a receiver are disclosed. In some embodiments, the method comprises generating control data indicative of a receiver-accessible source of personalized content for the viewer and inserting the control data into a plurality of control streams for transmission to the receiver, each of the control streams being accessible to the receiver when in a different respective operational state. The type of personalized content may include, but is not limited to, an instant message, an e-mail message, a file, a personalized report, a new television channel within a system for causing a channel change, a pay-per-view program, a video-on-demand program, a personalized message, etc.
Patent CA-2571749-A1 (CA)
Inventor: SCHMIDT MARK S
IPC: H04L29/06
Filed: 2006-12-19
Abstract: Method and apparatus for encoding a protocol data unit (PDU) stream is described. In one example, packets of the PDU stream are outer coded to produce a symbol stream. The symbol stream is formatting to produce trellis groups. The trellis groups are formed into blocks of MxN groups. For each of the blocks, M groups are processed using N trellis encoders to produce N  trellis encoder outputs. Each of the N trellis encoder outputs is mapped onto a quadrature amplitude modulation (QAM) constellation to generate N QAM  symbol streams. In another example, a single shared trellis encoder is used and channel bond grouping is performed on the encoded QAM symbols.
Patent CA-2572185-A1 (CA)
Inventor: KONING FRITS
IPC: A23L7/10
Filed: 2005-06-01
Abstract: Provided is a mAb-based method for the detection of T cell stimulatory epitopes known to be involved in CD. The method has many advantages compared to the existing methods for the detection of gluten since it is the first method that can; (i) detect T cell stimulatory epitopes of gluten; (ii) detect the epitopes separately, (iii) detect T cell stimulatory epitopes present on gliadin and glutenin homologues present in other cereals also known to be involved in CD; and (iv) detect T cell stimulatory epitopes on both intact proteins and small protein fragments. The new method is a valuable tool in the screening of basic ingredients, semi manufactured ingredients and food products that are intended to be used in the gluten free diet of CD patients.  Moreover the new method can also be used for the screening of cereals and different wheat varieties for the level of toxicity for CD patients. Thereby the method can help in the selection of cereals and wheat varieties with low toxicity which might form the basis for future breeding programs. In the future these cereals will be used for the production of safe food for CD  patients.
Patent CA-2572504-A1 (CA)
Title: Intracorneal lens placement method and apparatus
Inventor: FEINGOLD VLADIMIR
IPC: A61F9/00
Filed: 2005-07-01
Abstract: A corneal-pocket keratome and a method of cutting a corneal pocket. The keratome support assembly has a support made from a single piece and has a guide at forward position that has a transition surface and a well. A blade is mounted on the assembly with a blade edge that is concentrically spaced from the well to establish a predetermined space measure rearward and below the well.
Patent CA-2574684-A1 (CA)
Title: Hairpiece and method of making same
Inventor: KUPITZ ERWIN
IPC: A41G3/00
Filed: 2005-07-19
Abstract: A hair replacement or hairpiece that comprises a base woven with natural human hair, color amended and attached such as to simulate a natural growth pattern, hair density and hairline appearance and a method for making same. The hairpiece comprises a base with a front area (12) comprised of coated lace, a back area (18) comprised of about three pieces and reinforced with polyurethane; a knotting pattern wherein the front and crown areas are comprised of hair fired to the base with single hair split knots, the side and top areas are comprised of hair fired to the base with alternating single hair flat knots and single hair split knots and the back area comprises hair fixed to the base with single hair flat knots; and a color pattern wherein the base comprises about three color regions comprising a lighter shade in the front, a medium shade in the top and crown areas, and a darker shade in the back area.  The knotting pattern is further defined by the directions of the knots, which are either in a crisscross pattern, in a vertical, downward direction, or a horizontal, forward direction. The hairpiece further comprises a hairline comprising hair fixed to the base with single hair split knots fixed to the base in a horizontal, backward direction. Furthermore, the hairpiece comprises natural human hair, wherein the color of the natural hair is enhanced.
Patent CA-2577251-A1 (CA)
Title: Pyrimidine derivatives
Inventor: IMBACH PATRICIA
IPC: A61P35/00
Filed: 2005-08-26
Abstract: Novel pyrimidine derivatives of formula (I) to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.
Patent CA-2579566-A1 (CA)
Title: Adsorptive filtering material with integrated particle-and/or aerosol-filtering function and use thereof
Inventor: VARGA-MOLNAR ANNA
IPC: B01J20/28
Filed: 2007-02-26
Abstract: The invention relates to an adsorptive filtering material endowed with integrated particle- and/or aerosol-protection and with protective performance with regard to biological and/or chemical noxiants, in particular biological and/or chemical warfare agents, the adsorptive filtering material having a multilayered construction comprising a support layer, an adsorptive layer associated to and preferably fixed to the support layer, and optionally a covering layer disposed on that side of the adsorptive layer that is remote from the support layer, wherein the adsorptive filtering material is additionally equipped with a particle- and/or aerosol-filtering layer. The adsorptive filtering material is particularly useful in NBC protective materials of any kind (as in protective apparel for example) and for producing filters.
Patent CA-2580792-A1 (CA)
Inventor: GOLDBERG STEVEN G
IPC: A61M5/00
Filed: 2005-09-19
Abstract: A handheld instrument for minimizing pain during administration by injection of a liquid, such as, an anesthetic that has a main body, a vibration unit mounted in the main body when initiated to cause the main body to vibrate, and a detachable tip cantilever mounted on the main body to vibrate with it, the tip having a free end characterized by a bifurcation to form two spaced projections defining a space between them, whereby the spaced projections can be placed in proximity to, adjacent to and bracketing a preselected injection site on a human or animal and the tissue at said preselected injection site and vibrated while an injection is given.
Patent CA-2582443-A1 (CA)
Title: Distribution methods for distributing and dispensing beverages and liquid food products
Inventor: DAVIES DAVID
IPC: B65B3/17
Filed: 2005-02-28
Abstract: Disclosed is a method of distributing beverages or liquid food products including transportation, by a commercial distributor, or flexible bags (10) filled with the beverage or liquid food products. Flexible bags (10) are located in the bulk transport containers (30) and transported to consumers of the product in required quantities. Flexible bags (10) are delivered to a consumer, the beverage or liquid food product being dispensed for consumption ban an end consumer. Through each step in the distribution method, hazard and critical control points during distribution and dispensing are minimised, the ~one way~ nature of the preferred embodiment of the method minimising recovery and recycling costs at well as potential hygiene problems associated with re-use of containers currently in use.
Patent CA-2583986-A1 (CA)
Inventor: BLACKBURN MICHAEL R
IPC: A61P11/06
Filed: 2005-10-14
Abstract: The present invention relates to methods of preventing airway remodeling using A2B adenosine receptor antagonists. This invention finds utility in the treatment and prevention of asthma, COPD, pulmonary fibrosis, emphysema, and other pulmonary diseases. The invention also relates to pharmaceutical compositions for use in the method.
Patent CA-2585268-A1 (CA)
Title: Methods for lowering hif-1 mediated gene expression
Inventor: LU HUASHENG
IPC: A61K31/198
Filed: 2005-10-25
Abstract: The present invention relates to the elucidation of specific molecular features of endogenous amino acids and their derivatives for inhibiting hypoxia-inducible gene expression by preventing inactivation of hypoxia-inducible factor hydroxylating enzymes. This invention encompasses agents that can be used to reduce tissue vascularization, cancer cell survival, and to treat obesity.
Patent CA-2585450-A1 (CA)
Title: Expandable intervertebral spacer method and apparatus
Inventor: ENSIGN MICHAEL D
IPC: A61F2/44
Filed: 2005-10-25
Abstract: An expandable interbody spacer (IBS) device designed to restore the disc height between vertebral bodies. The expandable interbody spacer device has an integral, moveable expansion member or spreader, provided between two plates.  The plates are connected by one or more connecting members that retain the plates in a position proximate to one another while allowing the plates to move from a first unexpanded position to a second expanded position upon activation of the expansion member. According to aspects of the invention, the interbody spacer device can be implanted in an unexpanded or collapsed configuration, and then expanded to full height by engaging the expansion member. In other embodiments, the interbody spacer device may take various forms, for example, it may be cashew, rectangular or annular.
Patent CA-2585638-A1 (CA)
Title: Aminopyridine derivatives having aurora a selective inhibitory action
Inventor: OHKUBO MITSURU
IPC: A61K33/243
Filed: 2005-10-25
Abstract: A compound represented by the following general formula [I] or its pharmaceutically acceptable salt or ester, an Aurora-A selective inhibitor or an anticancer agent containing the same, and the combined use of the above anticancer agent with another anticancer agent: [I] wherein m1 and m2 represent each 1, 2 or 3; n1 and n2 represent each 0 or 1; i is an integer of from 1 to m1; j is an integer of from 1 to m2; R represents optionally substituted aryl, heteroaryl or cycloalkyl; Ral and Ral~ represent each hydrogen, etc.; Rbj and Rbj~ represent each hydrogen, etc.; Rc, Rd and Re represent each hydrogen, etc.; X1 represents CH, CX1a or N; X2 represents CH, N, etc.; X3 represents CH, N, etc.; X4 represents CH, N, etc.; Y1, Y2 and Y3 are the same or different and each represents CH or N; Z1 and Z2 are the same or different and each represents CH or N; and W represents a 5-membered aromatic heterocycle such as pyrazole or thiazole.
Patent CA-2586049-A1 (CA)
Title: Draw forming method and device
Inventor: MONDA TAKANORI
IPC: B21D22/22
Filed: 2005-11-11
Abstract: A draw forming method for drawing a blank material (15). In this method, a restraint region (98) that is an outer peripheral section (21) of the blank material is held by a first holder means (22), and then a tension region (97) inside the outer peripheral section is displaced upward by a second holder means (23) relative to the restraint region. The displacement applies tensile force to a drawing region (96) that is the central section of the blank material.
Patent CA-2586373-A1 (CA)
Inventor: REINDLE MARK E
IPC: H04M1/57
Filed: 2003-03-25
Abstract: A method and apparatus for selectively sending a false system information tone (SIT) in response to an incoming telephone call is provided.  One embodiment of the apparatus includes a telephone line interface, caller identification (caller ID) module, programmable oscillator, display device, and controller.  In another embodiment, the apparatus includes a data storage module, telephone line interface, caller ID module, programmable oscillator, display device, controller, and one or more control devices. The method includes the steps of: a) detecting a ring on the telephone line, b) receiving information about a calling party associated with the incoming telephone call, c) determining if a false SIT is to be sent based on the calling party information, and, d) if the false SIT is to be sent, i) determining when the false SIT is to be sent; ii) generating the false SIT; and, iii) sending the false SIT at the determined time.
Patent CA-2586586-A1 (CA)
Title: Optical calibration system and method
Inventor: ABAKOUMOV DMITRI
IPC: H04J14/02
Filed: 2005-11-08
Abstract: In an optical system including an optical input port for projecting an input optical signal onto an optical phased matrix array, an optical phased matrix array including a plurality of individually addressable pixels thereon, each said pixel being drivable within a prescribed range of levels, and an optical output port for collecting a predetermined fraction of said optical signal received from said optical phased matrix array; a method of compensating for phase distortions including the steps of: (a) determining a plurality of transfer functions relating said level of each said pixel to the phase variation each said pixel introduces to light from said input optical signal which is incident thereon; and (b) controlling the level of selected ones of said pixels in accordance with a corresponding transfer function such that said fractional signal received at said output port is modified in phase to substantially compensate for optical phase distortions arising from said optical phased matrix array.